A Canadian Cost Impact Analysis Comparing Maintenance Therapy with Bortezomib Versus Lenalidomide in Multiple Myeloma Patients Ineligible for Stem Cell Transplant

May 1, 2014, 00:00
10.1016/j.jval.2014.03.446
https://www.valueinhealthjournal.com/article/S1098-3015(14)00497-5/fulltext
Title : A Canadian Cost Impact Analysis Comparing Maintenance Therapy with Bortezomib Versus Lenalidomide in Multiple Myeloma Patients Ineligible for Stem Cell Transplant
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00497-5&doi=10.1016/j.jval.2014.03.446
First page : A76
Section Title : Cancer
Open access? : No
Section Order : 1492
Categories :
Tags :
Regions :
ViH Article Tags :